Buterizine

This classification denotes a vasodilating agent with the molecular formula C31H38N4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier N8516V0WOM, chemically known as 1h-benzimidazole, 2-butyl-5-((4-(diphenylmethyl)-1-piperazinyl)methyl)-1-ethyl but generally known as buterizine, which bears US NIH Compound Identifier 189902. European Medicines Agency schedules Buterizine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06013MIG. The term BUTERIZINE is an International Non-Proprietary Name. BUTERIZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule buterizine under HS 29335995 and SITC 51576. As of Q4 2014, BUTERIZINE remains the US FDA Preferred Term for this commodity. Buterizine bears US NLM identifiers UMLS ID C2698575 and NCI Concept Code C74422. SMILES: N1(CCN(CC1)Cc1cc2nc(n(c2cc1)CC)CCCC)C(c1ccccc1)c1ccccc1.